AC Immune (ACIU) Invested Capital (2016 - 2025)
AC Immune (ACIU) posted quarterly Invested Capital of $18.4 million for Q4 2025, down 20.3% year-over-year from $23.0 million in Q4 2024, and down 20.3% quarter-over-quarter from $23.0 million in Q4 2024.
AC Immune (ACIU) Invested Capital (2016 - 2025) Analysis & Trends
AC Immune (ACIU) has reported Invested Capital for 10 consecutive years, with $18.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Invested Capital fell 20.3% year-over-year to $18.4 million; the TTM figure through Mar 2026 stood at $18.4 million (down 20.3% YoY), while the FY2025 annual figure was $17.7 million, down 23.17% from the prior year.
- Invested Capital retreated to $18.4 million in Q4 2025 per ACIU's latest filing, from $23.0 million in the prior quarter.
- Across five years, Invested Capital topped out at $23.5 million in Q4 2021 and bottomed at $13.6 million in Q4 2022.
- Historically, Invested Capital has averaged $19.4 million across 5 years, with a median of $18.4 million in 2025.
- Annual changes were most pronounced in 2021 — Invested Capital soared 37.01% — and 2022, when it plunged 41.87%.
- AC Immune's Invested Capital stood at $23.5 million in 2021, then slumped by 41.87% to $13.6 million in 2022, then soared by 34.35% to $18.3 million in 2023, then advanced by 25.66% to $23.0 million in 2024, then dropped by 20.3% to $18.4 million in 2025.
- Business Quant data shows ACIU's Invested Capital at $18.4 million in Q4 2025, $23.0 million in Q4 2024, and $18.3 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.36 Mn |
| Dec 31, 2024 | 23.04 Mn |
| Dec 31, 2023 | 18.33 Mn |
| Dec 31, 2022 | 13.65 Mn |
| Dec 31, 2021 | 23.48 Mn |
| Dec 31, 2020 | 17.14 Mn |
| Sep 30, 2020 | 336,773.30 |
| Jun 30, 2020 | 333,137.61 |
| Mar 31, 2020 | 334,966.30 |
| Dec 31, 2019 | 15.00 Mn |
| Sep 30, 2019 | 338,993.75 |
| Jun 30, 2019 | 328.11 |
| Mar 31, 2019 | 337,365.01 |
| Dec 31, 2018 | 12.98 Mn |
| Dec 31, 2017 | 10.03 Mn |
| Dec 31, 2016 | 9.40 Mn |